Insights

Switching pediatric patients from hemodialysis (HD) to online hemodiafiltration (OL-HDF) significantly reduced P-wave dispersion (PWD), a predictor of atrial fibrillation (AF). This suggests OL-HDF may lower AF risk in children undergoing renal replacement therapy.

Area of Science:

  • Cardiology
  • Nephrology
  • Pediatrics

Background:

  • P-wave dispersion (PWD) is a predictor of paroxysmal atrial fibrillation (AF).
  • The impact of hemodialysis (HD) on PWD and AF risk is not fully understood.
  • Online hemodiafiltration (OL-HDF) is a renal replacement therapy.

Purpose of the Study:

  • To investigate the effect of switching from conventional HD to OL-HDF on PWD in pediatric patients.
  • To assess whether OL-HDF influences the risk of developing AF in this population.

Main Methods:

  • Thirty-three pediatric patients on HD were switched to OL-HDF for 6 months.
  • Echocardiography, 12-lead ECG, and PWD were measured before and after the switch.
  • A control group of 30 healthy children was included for comparison.

Main Results:

  • PWD significantly decreased after switching to OL-HDF (P < 0.001).
  • Fractional shortening also significantly improved (P < 0.001).
  • PWD in OL-HDF patients was still higher than in healthy controls, but significantly reduced from baseline.

Conclusions:

  • OL-HDF significantly reduces PWD in pediatric patients compared to conventional HD.
  • This reduction in PWD suggests a decreased potential for AF development.
  • OL-HDF may be a preferred renal replacement modality for pediatric patients due to its potential cardiovascular benefits.

Related Concept Videos

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
345
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.0K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
3.6K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505